TEHRAN –IRAN succeeded in producing cell therapy products approved by the Food and Pharmaceutical Bureau.
“Some genetic treatments are also in the clinical trial stage,” IRNA quoted the FDA director Mehdi Pirsalehi.
In terms of national scientific progress in the abilities of pharmaceuticals and Iranian scientists, the formula emphasized the importance of developing modern technology and using artificial intelligence in the pharmaceutical industry.
Approximately 99 % of medicine supplied to the domestic market is produced by Iranian knowledge -based companies. Pirsalehi has also added to the manufacture of biotechnology products using indigenous technology to meet the needs of the country. “
Exports of drugs increase
In the first half of the current year of Iran, which began on March 20, 2024, a drug worth $ 14.7 million was exported to 19.7 % year -on -year.
According to the Iranian customs bureau, exports have a volume of 49,400 tons, an increase of 15 % compared to last year’s synchronization.
Approximately 345 companies are involved in the production of pharmaceuticals, supplements, and raw materials, and are involved in the import of drugs in six months.
Pharmaceutical companies have imported a total of 54,800 tons of $ 1.1 billion, indicating that their value has decreased by 3.76 % compared to the same period of the previous year, and the value has increased by 4.5 %.
In June 2024, Seyyed Ali Maboudi, a stakeholder of the Food and Pharmaceutical Bureau, stated that FDA was planning to increase drug exports by 30 % during the middle term.
“In the past few years, medicine exports in Iran have a small share of non -oil exports. However, in the past year, it has experienced growth,” IRNA said MABOUDI. I quoted it.
Officials have pointed out that the exports of raw materials and pharmaceuticals in the past Iranian calendar (March 2024 to March 2024) are more than $ 100 million.
“The Food Pharmaceutical Bureau is planning to double the exports of medicine in the short term and 10 times in the long term,” said the authorities.
Considering the effects of drug health in all countries, Mabdi emphasized that they are one of the most complex types of exports, because they need to register and approve quality in each purpose. 。
mt/mg